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Introduction: Smokeless tobacco (ST) is a significant South Asian public health problem.  This paper 
reports a qualitative study of a sample of South Asian ST users. 
 
Methods: Interviews, using a piloted topic guide, with 33 consenting, urban dwelling adult ST users 
explored their ST initiation, continued use and cessation attempts. Framework data analysis was 
used to analyse country specific data before a thematic cross-country synthesis was completed. 
 
Results: Participants reported long term ST use and high dependency.  All reported strong cessation 
motivation and multiple failed attempts because of ease of purchasing ST, tobacco dependency and 
lack of institutional support. 
 
Conclusions: Interventions to support cessation attempts amongst consumers of South Asian ST 



























































































This study provides detailed understanding of the barriers and drivers to ST initiation, use and 
cessation for users in Bangladesh, India and Pakistan. It is the first study to directly compare these 
three countries. The insight was then used to adapt an existing behavioural support intervention for 

























































































Smokeless tobacco (ST) are non-combustible tobacco products that are chewed, snorted through the 
nose or placed in the oral cavity [1]. Consumed by more than 300 million people in at least 127 
countries, ST in 2017 is estimated to have caused over 90,000 deaths due to oral, pharynx and 
oesophageal cancers and a loss of 2.5 million disability adjusted life years [2]. ST use also correlates 
with increased cardiovascular mortality risk and poor pregnancy outcomes [2,3]. More than 85% of 
this disease burden concentrates in South and South East Asia [2]. 
 
The WHO Framework Convention on Tobacco Control (FCTC) [4] proposes a range of measures to 
reduce the consumption of tobacco products, including tobacco dependence treatment. 
Implementation of FCTC measures for ST products in general is limited [5], particularly with regard 
to cessation.  Barriers exist [6], with many countries lacking policy and appropriate quit services [7]. 
Adaptations are acknowledged as needed [8-12]. 
 
Data informing the process of developing appropriate interventions to support cessation attempts 
among people consuming South Asian ST products is lacking. This paper reports the results of a 
qualitative study of a sample of South Asian ST users used to inform the adaptation of a behavioural 


























































































South Asian ST users participated in a qualitative interview study of their ST initiation, continued use 
and cessation attempts. Ethical approvals were granted by the Health Sciences Research Governance 
Committee at the University of York, Bangladesh Medical Research Council (BMRC/NREC/2016-
2019/961), National Institute of Cancer Prevention and Research (NICPR) Institutional Ethics 
Committee (NICPR/116/DIR/Ethical/2018/02) and the National Bioethics Committee, Pakistan (4-
87/NBC-355/19/1695). 
 
Urban settings in Bangladesh, India and Pakistan were used and 10-12 per country, exclusive (non-
smoking), daily (for the past six months or at least 25 days in the past month) adult ST users were 
interviewed. Purposive sampling incorporated both sexes, varied education levels and users of 
various ST products. Participants were recruited from a primary care clinic, through local social 
workers, and community networks. Identified potential participants received study information and 
gave permission to share contact details before being contacted to arrange an interview.  
 
Face-to-face interviews were conducted in local languages by trained and mentored country 
research teams in locations ensuring privacy. Online methods and analysis training was delivered by 
an experienced UK based qualitative researcher (CJ). Before interview start, the researcher discussed 
the study information sheet and secured participant consent. Participants marked or initialled the 
item(s) to which they consented. To ensure consistency a topic guide was developed and piloted in 
all settings. Changes created better contextualisation of questions, a streamlined order and 
improved clarity. 
 
The audio-recorded interviews were transcribed verbatim, checked for accuracy by the interviewers 























































































each country. A thematic cross-country synthesis and interpretation was undertaken, and illustrative 
quotations (Supplementary Material 1) identified. The results were reviewed by all researchers. 
 
RESULTS 
Thirty-three ST users were interviewed between January-August 2019 (Table 1). Interviews lasted 
between 24 and 83 minutes. 
 
Smokeless tobacco initiation and use routines 
Length of ST use varied by gender and country, from 1.5-6 years for Indian women up to 45 years in 
Bangladeshi men. Pakistani participants had all used ST for at least 10 years. Types of ST used varied 
by country. In Bangladesh paan with zarda was commonly reported whilst guthka and khaini were 
preferred by Indian respondents. Regional variation was observed in Pakistan, with naswar used in 
Peshawar and guthka in Karachi.  Initiation triggers included curiosity, observation of others’ use or 
replacing behaviours such as smoking (Quotes 1,2, Supplementary Material 1). 
 
In Bangladesh and India women reported lower consumption frequencies than men (4-8 times/day 
compared to 15-40 in Bangladesh; 2-3 times/day compared to 7-8 in India). In Pakistan frequency 
ranged from 5-6 to 25-30 times/day. First daily intake was integrated into early morning routines 
(Quote 3, Supplementary Material 1) whilst later use might be solitary or with work colleagues, 
friends and family (Quote 4, Supplementary Material 1). Higher consumption was associated with 
social gatherings (Quote5, Supplementary Material 1) with a minority from all three countries 
describing use at weddings where non-users were also present. 
 
ST products were widely available in all three countries. Participants could buy ST throughout the 
day, with products being sold at stores, market stalls, tea stalls and vending carts, either close to 























































































Supplementary Material 1) with costs mainly described as insignificant. A Bangladeshi man reported 
his ST use impacted on his ability to provide for his family’s needs, whilst an Indian woman missed a 
meal to purchase ST which enabled her to continue working (Quote 8, Supplementary Material 1). 
 
Knowledge levels of ST product content varied. Some participants offered detailed descriptions 
whilst others identified only one or two ingredients. Different ingredient combinations of tobacco, 
ash, chuna, supari/betel nut, natural flavourings (e.g. lime), sweeteners (e.g. sweet syrup) and 
chemicals were reported. Men typically had better knowledge through observation of product 
preparation or recognition of contents through smell and taste.  
 
There was low awareness of ST systemic health risks. Participants might reflect on their own health, 
reporting headaches, chest pain, breathing difficulties, digestion problems and feeling weak (Quote 
9, Supplementary Material 1). Whilst many noted that use during pregnancy posed risks for the 
unborn child some women, from all three countries, reported their using ST during pregnancy 
without apparent adverse effects. The oral health risks were described as blackened teeth, halitosis, 
gum disease, mouth ulcers, oral cancers, cuts and thinning skin in the mouth. A Pakistani man and an 
Indian woman thought risks could b  mitigated by mouth rinsing after use. Knowledge of health risk 
and ingredients likely came from health warnings in the media whilst for some their doctor had 
advised against ongoing use due to personal risk (Quote 10, Supplementary Material 1). 
 
ST reportedly provided the benefits of pleasure, improved physical or mental vigour or therapeutic 
effects. While some reported enjoying the taste or chewing sensation, for others ST supported 
everyday functioning, assisting the fulfilment of work duties by increasing mental acuity, energy and 
physical strength or relieving nausea (Quote 11, Supplementary Material 1). Smokeless tobacco was 























































































constipation, toothache, headaches, tension, insomnia and agitation (Quote 12, Supplementary 
Material 1). 
 
A minority of participants also described the perceived negative health impacts of not using ST.  
These could be a reduced ability to work, feelings of malaise or imbalance, physical symptoms such 
as stomach problems, dizziness and seizures or mental health problems such as agitation and 
aggression (Quote 13, Supplementary Material 1). Participants did not believe they had sufficient 
willpower to succeed (Quote 14, Supplementary Material 1). 
 
Smokeless tobacco cessation 
People’s strong wishes to quit ST was striking (Quote 15, Supplementary Material 1). Three quarters 
of participants had attempted ST cessation, with attempts ranging from one to 20. Most attempts 
were of short duration (Quote 16, Supplementary Material 1). No participants had sought cessation 
support when trying to quit, even after following medical advice, and most perceived doctors and 
other health professionals as best placed to support cessation. Multiple alternative strategies had 
been used in cessation attempts, including willpower, not buying products, throwing products away, 
delaying use to later in daily routines, avoiding consumption and replacement with alternatives like 
sweet challia (betel nut) or fennel seeds. Strong dependency feelings rendered these behavioural 
regulation strategies ineffective (Quotes 17,18, Supplementary Material 1). 
 
Cessation might be associated with fears of disapproval and stigmatisation. Many reported 
chastisements by family (Quote 19, Supplementary Material 1) or work supervisors. Disapproval and 
quit requests led to concealment of use (Quote 20, Supplementary Material 1). Religious beliefs 
might also drive quit attempts. Some Pakistani and Bangladeshi men reported reductions in ST use 
during Ramadan and suggested religious leaders could encourage quitting. (Quote 21, 
























































































Most participants acknowledged possible adverse health consequences from ongoing use although 
some in Pakistan and India did not believe they would become ill. An Indian woman believed only 
people who were addicted or already unwell would be at risk of harm (Quote 22, Supplementary 
Material 1). Cessation intentions were impeded by positive physical sensations from ST use and 
negative physical withdrawal effects. Half the Bangladeshi and many Pakistani participants reported 
that whilst motivated by better health they felt addicted and powerless to stop. 
 
Fears of becoming ill, associated treatment costs and of dying were reported (Quote 23, 
Supplementary Material 1). Participants also recognised positive drivers for cessation, including 
improved oral health, providing a role model for younger generations (Quote 24, Supplementary 
Material 1) and financial benefits. These were insufficient to support successful cessation. 
 
DISCUSSION  
The disease burdens of ST use are concentrated in in South and South East Asia [2]. This is the first 
qualitative needs assessment synthesising the views of ST users across South Asia about their ST 
behaviours. The results would inform the adaptation of a ST cessation behavioural intervention [13]. 
The participant accounts confirm previously reported quantitative findings of long-term personal use 
and high dependency typical of South Asian ST users [9, 15-18]. This gives confidence that data 
saturation was achieved and that the findings are generalisable [14]. 
 
New data has emerged with respect to ST cessation. All reported strong cessation motivation but 
many failed attempts because of ease of purchasing ST, tobacco dependency and lack of institutional 
support. ST use among South Asians has been reported as culturally acceptable with strong social 
foundations [9]. Our participants reported a more nuanced role of significant others in their ST use.   























































































participants also described discouragement from younger family members and work supervisors 
which created a pressure to quit, stigmatising public ST use and encouraging lying about behaviour.  
 
Strengths and limitations of this study should be noted. We recruited men and women in three 
countries, across education levels, who used a variety of ST products and offered a diversity of views 
about their ST use. A key limitation was the failure to recruit women in one Pakistani location 
(Peshawar), reported to be because female ST use was considered culturally unacceptable. Secondly, 
we recruited from urban locations alone and acknowledge that ST use in rural areas may be more 
prevalent [15-17]. Further research should address this study’s limitations. 
 
Discouraging ongoing South Asian ST use requires population-level interventions to tackle 
opportunity factors, such as legislation, price increases and advertising bans [10], in addition to 
individual cessation support. This study suggests that implementation of policy measures and 
services for ST cessation is limited [5]. Most South Asian countries lack policy, including the provision 
of services in which appropriately adapted behavioural resources are embedded, to help in ST 
cessation. 
 
In conclusion, these South Asian ST users were highly motivated to attempt cessation yet were 
persistently unsuccessful because of socio-environmental factors encouraging ST initiation, 
persistent drivers to continue ST consumption and lack of formal cessation resources and support. 
Initiatives should address these challenges in developing an integrated ST control policy which 
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Table 1: Participant characteristics 
 Bangladesh India Pakistan 
Dhaka Rangpur Noida Karachi Peshawar 
Gender Male 4 2 7 4 4 
Female 3 2 5 2 0 
Age Up to 29 
years 
0 0 3 1 0 
30 to 39 
years 
0 2 3 2 1 
40 to 49 
years 
3 1 4 3 0 
50 to 59 
years 
1 1 0 0 2 
60 years 
and above 
3 0 2 0 1 
Marital 
status 
Married 4 4 10 5 4 
Single 0 0 0 1 0 
Widowed 3 0 1 0 0 
Did not 
report 





0 1 1 1 1 
Primary 2 1 3 1 1 
Secondary 4 2 6 3 1 
Higher and 
above 
1 0 1 0 1 
Did not 
report 
1 0 0 0 0 
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